MedPath

Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma

Not Applicable
Conditions
Hepatocellular Carcinoma
Interventions
Radiation: perfusion Computed Tomography
Registration Number
NCT03754192
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The aim of this study is to evaluate the hepatic perfusion computer tomography and dual energy computer tomography in the assessment of tumor characterization of Hepatocellular carcinoma in patients with resectable Hepatocellular carcinoma by comparing the quantitative parameters computer tomography obtained with the pathological data of the surgical specimens.

Detailed Description

Dual-energy computer tomography and perfusion computer tomography (General Electric revolution Hight definition Gemstone™ Spectral Imaging) will be performed in all patients. Iodine concentration and quantitative perfusion parameters of the Hepatocellular carcinoma and surrounding liver parenchyma data will be compared with the pathological results.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • A diagnosis of Hepatocellular carcinoma made according to the guidelines of the American Association for the study of the Liver
  • Affiliation to a national health insurance
  • An indication for hepatic resection during the decision-making stage
  • A request for a pre-operative Computer Tomography in our radiology unit
  • An affiliation to a social security
  • Informed consent given by the patient
Exclusion Criteria
  • Previous treatments of Hepatocellular carcinoma (medicated or surgical)
  • Patient under tutorship or curatorship
  • Pregnant or lactating woman

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
perfusion computed tomographyperfusion Computed TomographyWill be realsed before liver surgery
Primary Outcome Measures
NameTimeMethod
Pefusion parameters5 minutes

correlation between pre-operative imaging data and histological data of Hepatocellular carcinoma

Secondary Outcome Measures
NameTimeMethod
Pathological examination1 month

Compare data obtained in perfusion computer tomography to the imaging data and to the Histological differentiation grades

Trial Locations

Locations (1)

CHU Paul Brousse

🇫🇷

Villejuif, France

© Copyright 2025. All Rights Reserved by MedPath